Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (December 1999). "Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration". Nature. 402 (6762): 615–22. Bibcode:1999Natur.402..615P. doi:10.1038/45159. PMID10604467. S2CID4414281.
Paglini G, Cáceres A (March 2001). "The role of the Cdk5--p35 kinase in neuronal development". European Journal of Biochemistry. 268 (6): 1528–33. doi:10.1046/j.1432-1327.2001.02023.x. PMID11248669.
Cortés N, Guzmán-Martínez L, Andrade V, González A, Maccioni RB (2019). "CDK5: A Unique CDK and Its Multiple Roles in the Nervous System". Journal of Alzheimer's Disease. 68 (3): 843–855. doi:10.3233/JAD-180792. PMID30856110. S2CID75139185.
Franklin RJ, Ffrench-Constant C (November 2008). "Remyelination in the CNS: from biology to therapy". Nature Reviews. Neuroscience. 9 (11): 839–55. doi:10.1038/nrn2480. PMID18931697. S2CID1270678.
Piccolo S, Dupont S, Cordenonsi M (October 2014). "The biology of YAP/TAZ: hippo signaling and beyond". Physiological Reviews. 94 (4): 1287–312. doi:10.1152/physrev.00005.2014. PMID25287865.
Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, et al. (June 2000). "Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth". Neuron. 26 (3): 633–46. doi:10.1016/S0896-6273(00)81200-3. hdl:1721.1/83489. PMID10896159. S2CID15142577.
harvard.edu
ui.adsabs.harvard.edu
Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (December 1999). "Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration". Nature. 402 (6762): 615–22. Bibcode:1999Natur.402..615P. doi:10.1038/45159. PMID10604467. S2CID4414281.
nih.gov
pubmed.ncbi.nlm.nih.gov
Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (December 1999). "Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration". Nature. 402 (6762): 615–22. Bibcode:1999Natur.402..615P. doi:10.1038/45159. PMID10604467. S2CID4414281.
Paglini G, Cáceres A (March 2001). "The role of the Cdk5--p35 kinase in neuronal development". European Journal of Biochemistry. 268 (6): 1528–33. doi:10.1046/j.1432-1327.2001.02023.x. PMID11248669.
Cortés N, Guzmán-Martínez L, Andrade V, González A, Maccioni RB (2019). "CDK5: A Unique CDK and Its Multiple Roles in the Nervous System". Journal of Alzheimer's Disease. 68 (3): 843–855. doi:10.3233/JAD-180792. PMID30856110. S2CID75139185.
Franklin RJ, Ffrench-Constant C (November 2008). "Remyelination in the CNS: from biology to therapy". Nature Reviews. Neuroscience. 9 (11): 839–55. doi:10.1038/nrn2480. PMID18931697. S2CID1270678.
Piccolo S, Dupont S, Cordenonsi M (October 2014). "The biology of YAP/TAZ: hippo signaling and beyond". Physiological Reviews. 94 (4): 1287–312. doi:10.1152/physrev.00005.2014. PMID25287865.
"1D PFV: 1UNH". RCSB Protein Data Bank. Retrieved 2020-11-06.
semanticscholar.org
api.semanticscholar.org
Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (December 1999). "Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration". Nature. 402 (6762): 615–22. Bibcode:1999Natur.402..615P. doi:10.1038/45159. PMID10604467. S2CID4414281.
Cortés N, Guzmán-Martínez L, Andrade V, González A, Maccioni RB (2019). "CDK5: A Unique CDK and Its Multiple Roles in the Nervous System". Journal of Alzheimer's Disease. 68 (3): 843–855. doi:10.3233/JAD-180792. PMID30856110. S2CID75139185.
Franklin RJ, Ffrench-Constant C (November 2008). "Remyelination in the CNS: from biology to therapy". Nature Reviews. Neuroscience. 9 (11): 839–55. doi:10.1038/nrn2480. PMID18931697. S2CID1270678.